Across TCGA pan-cancer cohorts, CTSL3P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CTSL3P data layer compared with 2 for mutation status.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CTSL3P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CTSL3P expression acts as an unfavorable survival marker, although some lineages such as KIRP and SKCM show a favorable association.
STAD, LIHC, and KIRP are the cancer types where CTSL3P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.